Please provide your email address to receive an email when new articles are posted on . A validated score was able to predict among which patients with epilepsy stereoelectroencephalography was ...
Persistence has paid off for NeuroOne Medical Technologies, a company that develops electrode technology for diagnostic brain mapping procedures. NeuroOne's Evo sEEG system had previously been FDA ...
At least half of a small group of children and adolescents with difficult-to-localize refractory focal epilepsy was rendered seizure-free or much improved with stereoelectroencephalography (SEEG) ...
Peer-Reviewed Case Series Supports Safe Integration into Existing Stereotactic Workflow, Bedside Treatment Capability, and Reductions in Seizure Burden in Patients with Drug-Resistant Epilepsy* The ...
For pediatric patients with drug-resistant focal epilepsy, stereoelectroencephalography-guided radiofrequency thermocoagulation (SEEG-RFTC) is safe, with favorable outcomes for most patients, ...
“Much like tuning a high-precision radar to detect faint signals, SEEG enables clinicians to record subtle electrical signatures of seizures directly from deep brain structures,” says Dr. Jiajie Mo, ...
EDEN PRAIRIE, Minn., May 02, 2023 (GLOBE NEWSWIRE) -- NeuroOne Medical Technologies Corporation (NASDAQ: NMTC) ("NeuroOne" or the "Company"), a medical technology company focused on improving surgical ...
EDEN PRAIRIE, Minn., May 10, 2023 (GLOBE NEWSWIRE) -- NeuroOne Medical Technologies Corporation (NASDAQ: NMTC) ("NeuroOne" or the "Company"), a medical technology company focused on improving surgical ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results